Funding Rounds
Exogene

Exogene Pre Seed (2020, $0M)

Exogene

Biotechnology platform accelerating cancer cell therapy discoveries with AI-driven TCR-antigen screening.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Pre Seed

Raised Amount: $0.10M

Raised Date: 2020-01-01

Investors